IRONWOOD PHARMACEUTICALS INC - DBCV 2.250% 6/1

CUSIP: 46333XAD0

Q1 2019 13F Holders as of 31 Mar 2019

Type / Class
Debt / DBCV 2.250% 6/1
Market price (% of par)
110.31%
Total 13F principal
$292,319,200
Principal change
-$27,092,800
Total reported market value
$325,972,061
Number of holders
30
Value change
-$26,868,282
Number of buys
10
Number of sells
17

Quarterly Holders Quick Answers

What is CUSIP 46333XAD0?
CUSIP 46333XAD0 identifies 46333XAD0 - IRONWOOD PHARMACEUTICALS INC - DBCV 2.250% 6/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of IRONWOOD PHARMACEUTICALS INC - DBCV 2.250% 6/1 as of Q1 2019

As of 31 Mar 2019, IRONWOOD PHARMACEUTICALS INC - DBCV 2.250% 6/1 was held by 30 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $292,319,200 in principal (par value) of the bond. The largest 10 bondholders included CITADEL ADVISORS LLC, WOLVERINE ASSET MANAGEMENT LLC, DeepCurrents Investment Group LLC, UBS ASSET MANAGEMENT AMERICAS INC, BARCLAYS PLC, PRICE T ROWE ASSOCIATES INC /MD/, CAPSTONE INVESTMENT ADVISORS, LLC, CNH PARTNERS LLC, HBK INVESTMENTS L P, and Verition Fund Management LLC. This page lists 30 institutional bondholders reporting positions for the Q1 2019 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.